Academic - Industry Day Translational Dementia Research (Virtual Event)

The University of Oxford will be hosting a virtual AIMday in Translational Dementia Research on 30 May 2022 as part of the conference “21st Century Translational Dementia Research” that will bring together industry and academia to discuss key challenges. The AIMday format allows industry to propose challenges for one-hour roundtable discussions with groups of relevant academics and clinicians from Oxford. This is a great chance to see how your research can be applied in industry and to meet potential future collaborators.

Participating companies include: Akrivia Health, Ainostics, BrainBerry Ltd, Cumulus Neuroscience, Cytox, NeuroBio Ltd, Novo Nordisk, Olink, PharmaKure and Stratastem

If you would also like to attend the conference please register at: www.eventbrite.co.uk/e/21st-century-translational-dementia-research-conference-registration-257094766367

Date: 30 May 2022, 10:15 (Monday, 6th week, Trinity 2022)
Venue: Venue to be announced
Speaker: Various Speakers
Organising department: Medical Sciences Division
Organiser: Medical Sciences Division Business Partnerships Office (University of Oxford)
Organiser contact email address: betina.nair@medsci.ox.ac.uk
Booking required?: Required
Booking url: https://aimday.se/21st-century-translational-dementia-research-oxford-2022/registration-for-researchers/
Cost: Free
Audience: Members of the University of Oxford and Biotech/Pharma industry
This talk features in the following public collections:
Editor: Betina Nair